TechCapsules

Shionogi & Co., a Japanese pharmaceutical firm, won first place in the Quality of Life category of the NEDO Challenge for its quantum‑assisted drug‑discovery research conducted with D‑Wave. A peer‑reviewed study in Scientific Reports (July 2026) showed that a generative AI model integrated with D‑Wave’s annealing quantum computer produced chemically valid molecular representations 97 % of the time, versus 73 % for a comparable classical model, and yielded a higher share of molecules with strong drug‑likeness scores. The ¥40 million prize [...]

TechCrunch Disrupt 2026’s Startup Battlefield crowned Intero Biosystems, a Denver‑based company spun from the University of Michigan, as the winner. The 20 finalists, selected from the top 200 startups, pitched live demos to VCs and tech leaders. After deliberation, five finalists—Apate, Flox Intelligence, Intero Biosystems, Industrial Next, and Satlyt—advanced to the finale, where judges including Alexa von Tobel and Karl Alomar evaluated their solutions. Intero’s 1 mm intestinal organoids, sold as GastroScreen, enable drug and compound testing for [...]

Intero Biosystems, a Denver startup spun out of the University of Michigan, sells human intestinal organoids called GastroScreen that mimic the gut’s complex cell types. The 1‑mm organoids are shipped in batches of 100 and can be used to test drug safety, disease responses, or custom experiments. With seven employees and under ten customers, the company raised $2.3 million in pre‑seed funding and generated over $400,000 in revenue in its first year. FDA guidance encouraging non‑animal testing methods [...]

Science Corporation, led by former Neuralink co‑founder Max Hodak, implanted its PRIMA vision‑restoring chip into its first Stargardt disease patient during a trial at Sydney Eye Hospital. The two‑millimeter device replaces damaged outer retinal cells and receives visual input via camera‑equipped glasses, enabling the patient to see letters and words. PRIMA is already sold in Europe for geographic atrophy, and the company plans to expand the technology to other retinal disorders and broader brain‑computer interface applications. [...]

In 2001, amid the aftermath of the September 11 attacks, the United States experienced its first major bioterrorist incident when anthrax spores were mailed to media outlets in Florida and New York and to government offices in Washington, DC. The Amerithrax investigation identified 22 pulmonary anthrax cases, resulting in five deaths, and traced the spores to a possible U.S. Army laboratory, though no one was convicted after the primary suspect, microbiologist Bruce Ivins, died. The episode exposed fragmented inter‑agency communication, inadequate [...]

Researchers at Microsoft used the Discovery app to build a cloud‑deployable bioinformatics pipeline that helps identify bacteriophages capable of treating drug‑resistant bacterial infections. The workflow accepts a bacterial genome, flags antibiotic‑resistance genes, predicts antiphage defenses, and scans large environmental datasets for candidate phages. Each step is documented in an inspectable task tree, allowing scientists to trace decisions, validate methods, and adjust the approach in real time. The collaborative human‑agent process links literature, multi‑omics data, and analytical tools, [...]

Union Minister of State for Science and Technology Dr Jitendra Singh inaugurated the World Congress on Nanomedicine 2026 in New Delhi, emphasizing nanomedicine’s role in advancing precision and personalised healthcare. Speaking to more than 2,000 scientists, researchers, industry experts and students, he described nanomedicine as a transformative technology that operates at the scale of one‑billionth of a metre, enabling interventions at cellular and molecular levels. Singh highlighted that future treatments will be tailored to individual genetic, lifestyle and environmental factors, [...]

Anthropic announced that its Claude AI model independently identified a previously unknown enzyme system in bacteriophage DNA, resembling the CRISPR gene‑editing machinery. The discovery emerged from a 21‑hour search through 210 million tokens by nearly 950 Claude agents, with human oversight limited to an initial prompt and laboratory validation. One agent flagged a repeating pattern, leading to lab confirmation of the novel system. Anthropic positions the finding as a test of Claude’s scientific utility amid its expansion [...]